Fig. 3From: Pelvic bone marrow sparing intensity modulated radiotherapy reduces the incidence of the hematologic toxicity of patients with cervical cancer receiving concurrent chemoradiotherapy: a single-center prospective randomized controlled trialReceiver operating characteristic (ROC) curves for HT2+ as a function of LSS V10 (a), LSS Mean (b) and PB V40 (c)Back to article page